Eritrea vs Georgia: Access to anti-retroviral drugs, male
Eritrea
72.0%
in 2024
Georgia
72.0%
in 2024
Eritrea rank
65th
Georgia rank
65th
Access to anti-retroviral drugs, male over time
- Eritrea
- Georgia
How they compare
Eritrea currently reports 72.0% against 72.0% in Georgia, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Georgia ahead.
Eritrea ranks 65th and Georgia ranks 65th of 141 countries.
Across the 3 decades both report, Eritrea averaged higher in 1 and Georgia in 2.
Head to head by decade
| Decade | Eritrea | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.3% | 12.7% | 6.4% | Georgia |
| 2010s | 52.7% | 53.3% | 0.6% | Georgia |
| 2020s | 69.8% | 69.4% | 0.4% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Eritrea or Georgia?
- Eritrea, at 72.0% against 72.0% in Georgia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Eritrea and Georgia?
- 0.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Georgia?
- 25 years are reported by both, from 2000 to 2024.
- How do Eritrea and Georgia rank globally for access to anti-retroviral drugs, male?
- Eritrea ranks 65th and Georgia ranks 65th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.